Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Made Headway
Tue, Feb 21, 2023 at 07:11 PM
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE) shot up at $4.55, a gain of 40%. On Tue, Feb 21, 2023, AMAM:NYSE hit a New 2-Week High of $4.55. The stock got featured on our News Catalysts scanner on Thu, Feb 16, 2023 at 08:03 AM in the 'BIOTECH' category. From Tue, Feb 07, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
About Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE)
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code...
Top 10 Gainers:
- Atlas Lithium Corporation (ATLX:NASDAQ), 51.52%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 49.94%
- Kuke Music Holding Limited American Depositary Shares each representing one (KUKE:NYSE), 47.42%
- Harbor Custom Development Inc. (HCDI:NASDAQ), 45.71%
- Mobilicom Limited (MOB:NASDAQ), 41.29%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 40%
- LanzaTech Global Inc Com (LNZA:NASDAQ), 32.29%
- Versus Systems Inc. (VS:NASDAQ), 31.25%
- Troika Media Group Inc. (TRKA:NASDAQ), 28.12%
- Zedge, Inc. (ZDGE:NYSEMKT), 25.19%